Houte Hans van insider trades: Nurix Therapeutics (NRIX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Houte reports to the SEC
Open-market buys and sales
37 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 4, 2026 | NRIX | ↓ Sell | 4,769 | $15.63 | $75K | Direct | Nov 4, 2026 (0d) |
| Oct 30, 2026 | NRIX | ↓ Sell | 2,834 | $26.28 | $74K | Direct | Nov 2, 2026 (3d) |
| Aug 4, 2026 | NRIX | ↓ Sell | 4,761 | $24.36 | $116K | Direct | Aug 4, 2026 (0d) |
| Jul 30, 2026 | NRIX | ↓ Sell | 2,845 | $23.38 | $67K | Direct | Jul 30, 2026 (0d) |
| May 5, 2026 | NRIX | ↓ Sell | 14,055 | $16.60 | $233K | Direct | May 5, 2026 (0d) |
| Apr 30, 2026 | NRIX | ↓ Sell | 2,388 | $16.65 | $40K | Direct | Apr 30, 2026 (0d) |
| Jan 30, 2026 | NRIX | ↓ Sell | 3,661 | $16.60 | $61K | Direct | Jan 30, 2026 (0d) |
| Nov 3, 2025 | NRIX | ↓ Sell | 6,284 | $12.56 | $79K | Direct | Nov 3, 2025 (0d) |
| Oct 30, 2025 | NRIX | ↓ Sell | 3,130 | $12.80 | $40K | Direct | Oct 30, 2025 (0d) |
| Aug 1, 2025 | NRIX | ↓ Sell | 5,402 | $11.03 | $60K | Direct | Aug 1, 2025 (0d) |
| Jul 30, 2025 | NRIX | ↓ Sell | 4,304 | $12.01 | $52K | Direct | Jul 30, 2025 (0d) |
| May 2, 2025 | NRIX | ↓ Sell | 6,198 | $11.33 | $70K | Direct | May 2, 2025 (0d) |
| Apr 30, 2025 | NRIX | ↓ Sell | 2,438 | $11.50 | $28K | Direct | Apr 30, 2025 (0d) |
| Mar 3, 2025 | NRIX | ↓ Sell | 5,825 | $14.49 | $84K | Direct | Mar 3, 2025 (0d) |
| Jan 30, 2025 | NRIX | ↓ Sell | 2,811 | $19.85 | $56K | Direct | Jan 30, 2025 (0d) |
| Nov 1, 2024 | NRIX | ↓ Sell10b5-1 | 3,546 | $24.28 | $86K | Direct | Nov 1, 2024 (0d) |
| Oct 30, 2024 | NRIX | ↓ Sell | 2,368 | $24.30 | $58K | Direct | Oct 30, 2024 (0d) |
| Aug 26, 2024 | NRIX | ↓ Sell10b5-1 | 20,000 | $25.22 | $504K | Direct | Aug 26, 2024 (0d) |
| Aug 1, 2024 | NRIX | ↓ Sell10b5-1 | 3,477 | $21.45 | $75K | Direct | Aug 1, 2024 (0d) |
| Jul 30, 2024 | NRIX | ↓ Sell | 2,490 | $20.67 | $51K | Direct | Jul 30, 2024 (0d) |
| Jun 20, 2024 | NRIX | ↓ Sell | 20,000 | $20.01 | $400K | Direct | Jun 20, 2024 (0d) |
| May 2, 2024 | NRIX | ↓ Sell10b5-1 | 3,499 | $12.83 | $45K | Direct | May 2, 2024 (0d) |
| Apr 30, 2024 | NRIX | ↓ Sell | 1,387 | $12.04 | $17K | Direct | Apr 30, 2024 (0d) |
| Feb 16, 2024 | NRIX | ↓ Sell | 6,812 | $10.02 | $68K | Direct | Feb 16, 2024 (0d) |
| Jan 30, 2024 | NRIX | ↓ Sell | 1,671 | $7.99 | $13K | Direct | Jan 30, 2024 (0d) |
| Dec 20, 2023 | NRIX | ↓ Sell | 3,541 | $10.00 | $35K | Direct | Dec 21, 2023 (1d) |
| Dec 19, 2023 | NRIX | ↓ Sell | 10,906 | $10.00 | $109K | Direct | Dec 20, 2023 (1d) |
| Oct 31, 2023 | NRIX | ↓ Sell | 1,080 | $5.20 | $6K | Direct | Nov 1, 2023 (1d) |
| Jul 31, 2023 | NRIX | ↓ Sell | 1,245 | $9.65 | $12K | Direct | Aug 1, 2023 (1d) |
| May 1, 2023 | NRIX | ↓ Sell | 721 | $9.88 | $7K | Direct | May 2, 2023 (1d) |
| Jan 30, 2023 | NRIX | ↓ Sell | 924 | $11.78 | $11K | Direct | Feb 1, 2023 (2d) |
| Oct 31, 2022 | NRIX | ↓ Sell | 739 | $12.88 | $10K | Direct | Nov 1, 2022 (1d) |
| Aug 1, 2022 | NRIX | ↓ Sell | 752 | $15.67 | $12K | Direct | Aug 2, 2022 (1d) |
| May 2, 2022 | NRIX | ↓ Sell | 697 | $11.75 | $8K | Direct | May 3, 2022 (1d) |
| Feb 24, 2021 | NRIX | ↓ Sell | 35,419 | $39.90 | $1.4M | Direct | Feb 25, 2021 (1d) |
| Feb 22, 2021 | NRIX | ↓ Sell | 5,330 | $39.93 | $213K | Direct | Feb 23, 2021 (1d) |
| Feb 18, 2021 | NRIX | ↓ Sell | 13,583 | $35.46 | $482K | Direct | Feb 22, 2021 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other NRIX insiders
Open-market trades in the last 12 months
About Houte Hans van's insider trades
Houte Hans van is Chief Financial Officer at Nurix Therapeutics (NRIX). Since Feb 18, 2021, Houte has reported no open-market purchases and 37 sales worth $4.8M on SEC Form 4. In the last 12 months: 7 sales ($665K).
4 sales (15% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include option exercises (23 filings), grants and awards (7 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NRIX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.